We firstly evaluated the in vitro cytotoxic responses of 1928zT2 T cells exposed to NALM-6 cells (a CD19+ human B-ALL cell line), K562-GL cells with or without CD19 expression. This evidence concerns the gene CD19 and acute lymphoblastic leukemia.